Cyfra 21-1 – Tumor Marker Analysis
550,00 د.إThe Cyfra 21-1 test is a specialized tumor marker analysis. It measures the levels of Cytokeratin 19 fragments in your blood serum.
Sample Type : Serum
Methodology : TBA
TAT : 10 Days
Showing all 4 results

The Cyfra 21-1 test is a specialized tumor marker analysis. It measures the levels of Cytokeratin 19 fragments in your blood serum.
Sample Type : Serum
Methodology : TBA
TAT : 10 Days


Trucheck™ Intelli: A Pioneering Blood Test for Proactive Cancer Signal Detection Expert Insight from Lab Tests Dubai: As a trusted diagnostic partner, we provide access to cutting-edge technologies like Trucheck™ Intelli. This information is reviewed for accuracy to support informed healthcare decisions. This test represents a significant advancement in non-invasive oncology screening. The future of…

Tumor Markers Screen (Female) is a powerful, non-invasive blood test that measures five critical tumor markers: CEA, CA 15.3, CA 19.9, CA 125, and AFP.
Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day